MedPath

Hyoscine before hysteroscopy

Phase 2
Conditions
Condition 1: cervical stenosis,. Condition 2: Endometrial polyp.
Stricture and stenosis of cervix uteri
Polyp of corpus uteri
N88.2
N84.0
Registration Number
IRCT20140224016705N13
Lead Sponsor
Shahid Beheshti University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Female
Target Recruitment
120
Inclusion Criteria

All people who underwent hysteroscopy in Mahdieh Hospital

Exclusion Criteria

People who are allergic to prostaglandins or hyoscine.
People with a history of cervical injury or surgery.
People with active cervical infection.
Glaucoma
History of cardiovascular disease and tachycardia
People have recently been treated with estrogen.
pregnancy

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Cervical lacerations rate. Timepoint: during hysteroscopy. Method of measurement: presence of lacerations or canals.;Entrance of hysteroscope into cervix. Timepoint: Start of hysteroscopy. Method of measurement: Likert scale.;Uterine perforations. Timepoint: During surgery. Method of measurement: Based on serum deficit or surgeon experience.;Post-op pain/ use of analgesics. Timepoint: for 24 hours after procedure. Method of measurement: Visual Analogue Scale.
Secondary Outcome Measures
NameTimeMethod
Drug side effects. Timepoint: 12 hours after drug administration. Method of measurement: based on patient vital signs and general conditions.
© Copyright 2025. All Rights Reserved by MedPath